GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TTY Biopharm Co Ltd (ROCO:4105) » Definitions » Market Cap

TTY Biopharm Co (ROCO:4105) Market Cap : NT$19,047 Mil (As of Apr. 27, 2024)


View and export this data going back to 2001. Start your Free Trial

What is TTY Biopharm Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). TTY Biopharm Co's share price for the quarter that ended in Dec. 2023 was NT$80.4. TTY Biopharm Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 249 Mil. Therefore, TTY Biopharm Co's market cap for the quarter that ended in Dec. 2023 was NT$19,991 Mil.

TTY Biopharm Co's quarterly market cap declined from Jun. 2023 (NT$19,494 Mil) to Sep. 2023 (NT$19,196 Mil) but then increased from Sep. 2023 (NT$19,196 Mil) to Dec. 2023 (NT$19,991 Mil).

TTY Biopharm Co's annual market cap increased from Dec. 2021 (NT$17,107 Mil) to Dec. 2022 (NT$20,737 Mil) but then declined from Dec. 2022 (NT$20,737 Mil) to Dec. 2023 (NT$19,991 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. TTY Biopharm Co's Enterprise Value for Today is NT$18,145 Mil.


TTY Biopharm Co Market Cap Historical Data

The historical data trend for TTY Biopharm Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TTY Biopharm Co Market Cap Chart

TTY Biopharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20,488.76 17,057.39 17,107.12 20,737.41 19,991.46

TTY Biopharm Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20,737.41 18,947.13 19,494.16 19,195.78 19,991.46

Competitive Comparison of TTY Biopharm Co's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, TTY Biopharm Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TTY Biopharm Co's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TTY Biopharm Co's Market Cap distribution charts can be found below:

* The bar in red indicates where TTY Biopharm Co's Market Cap falls into.



TTY Biopharm Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

TTY Biopharm Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=NT$80.4*248.65
=NT$19,991

TTY Biopharm Co's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=NT$80.4*248.65
=NT$19,991

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TTY Biopharm Co  (ROCO:4105) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


TTY Biopharm Co Market Cap Related Terms

Thank you for viewing the detailed overview of TTY Biopharm Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


TTY Biopharm Co (ROCO:4105) Business Description

Traded in Other Exchanges
N/A
Address
No. 3-1, Park Street, 3rd Floor, Nangang District, Taipei, TWN, 11503
TTY Biopharm Co Ltd is engaged in the manufacturing and marketing of pharmaceuticals and chemical drugs. The company's operating segment includes Oncology, Health Care, Anti-Infection, Domestic Cardiovascular and Gastrointestinal Drugs, and other segments. It generates maximum revenue from the Oncology segment. Geographically, it derives a majority of revenue from Taiwan and also has a presence in European and Other Countries. Some of its products include Algitab, Alginos, Sulfin, Metacin, Cepiro, Brosym, Colimycin, Cubicin, and others.

TTY Biopharm Co (ROCO:4105) Headlines

No Headlines